COMIRNATY

Google image searchProduct monograph

Active ingredient

*sarscov2 s-protein mrna, 5'[m27,3'-ogppp(m12'-o)apg], 3'polya+linker, 30 MCG/0.3 ML

DIN: 02541823

Dosage form(s): SUSPENSION

Route(s) of administration: INTRAMUSCULAR

Description: SINGLE DOSE VIAL AND MULTIDOSE VIAL

Schedule: Schedule D

Company: BIONTECH MANUFACTURING GMBH

Date: 30-SEP-2024

ATC:

• J07 — VACCINES (ATC, ATC/DDD, )
• J07B — VIRAL VACCINES (ATC, ATC/DDD)
• J07BN — Covid-19 vaccines (ATC, ATC/DDD)
• J07BN01 — COVID-19, RNA-BASED VACCINE (ATC/DDD)

Reference brand drug: Comirnaty, Spikevax

External Links for Comirnaty

Search on Google

• Comirnaty side effects
• Comirnaty dosage
• *sarscov2 s-protein mrna, 5'[m27,3'-ogppp(m12'-o)apg], 3'polya+linker side effects
• *sarscov2 s-protein mrna, 5'[m27,3'-ogppp(m12'-o)apg], 3'polya+linker dosage